Fortress Biotech Stock Earnings Reports
FBIO Upcoming Earnings (Q3 2023)
Earnings Date: | Nov 13, 2023 |
Consensus EPS: | Premium |
Current P/E* ratio: -0.263 | Price (Sep 29, 2023, EOD): $0.290
*The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.
Last 3 Quarters for FBIO Premium
FAQ
About Fortress Biotech
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules... FBIO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.